| Characteristics |
Corresponding value |
| Age(years) |
|
| Mean±SDMedian |
42.7±1.4 |
| Distributionn(%) |
45 |
| 10-19 |
27 (7.4%) |
| 20-29 |
53 (14.4%) |
| 30-39 |
68 (18.5%) |
| 40-49 |
66 (18%) |
| 50-59 |
111 (30.2%) |
| 60-69 |
37 (10.1%) |
| 70-79 |
5 (1.4%) |
| Sex |
|
| Female(n[%]) |
186 (50.7%) |
| Male (n[%]) |
181 (49.3%) |
| Cancer Type (n [%]) |
|
| Gastro-intestinal |
108 (29.4%) |
| Head and Neck |
69 (18.8%) |
| Genitourinary |
60 (16.3%) |
| Sarcoma |
46 (12.5%) |
| Others |
84 (22.9%) |
| Metastasis stage determined (n [%]) |
184 (50.1%) |
| Metastasis stage IV cancer (n [%]) |
68 (18.5%) |
| Co-morbidity exist (n [%] |
80 (21.8%) |
| Number of medications |
|
| Mean + SD |
6.4 + 0.97 |
| Median |
6.0 |
| Minimum |
4 |
| Maximum |
10 |
| Length of Hospital stay (days) |
|
| Mean + SD |
2.6+2.4 |
| Median |
2 |
| 1-2 days (n [%]) |
209 (56.9%) |
| 3-5 days (n [%]) |
150 (40.9%) |
| 6 days (n [%]) |
8 (2.2%) |
|
